Short-term cardiotoxicity and early echocardiographic changes following autologous hematopoietic stem cell transplantation: a single-center retrospective analysis - Summary - MDSpire

Short-term cardiotoxicity and early echocardiographic changes following autologous hematopoietic stem cell transplantation: a single-center retrospective analysis

  • By

  • Jean El Cheikh

  • Maria El Tannir

  • Ali Awada

  • Ali Tarhini

  • Nour Moukalled

  • Iman Abou Dalle

  • Omar Fakhreddine

  • Walid Gharzuddin

  • Ali Bazarbachi

  • Hadi Skouri

  • May 28, 2026

  • 0 min

Share

Objective:

To evaluate echocardiographic changes occurring within the first 100 days after autologous stem cell transplantation (ASCT).

Key Findings:
  • Correct the prevalence of valvular abnormalities to reflect the accurate numbers from the source.
Interpretation:

Remove unsupported conclusions about the significance of findings.

Limitations:
  • Single-center study may limit generalizability.
  • Retrospective design may introduce selection bias.
Conclusion:

Remove speculative language regarding future studies and implications.

Original Source(s)

Short-term cardiotoxicity and early echocardiographic changes following autologous hematopoietic stem cell transplantation: a single-center retrospective analysis

  • by Jean El Cheikh, Maria El Tannir, Ali Awada, Ali Tarhini, Nour Moukalled, Iman Abou Dalle, Omar Fakhreddine, Walid Gharzuddin, Ali Bazarbachi, Hadi Skouri

  • May 28, 2026

Related Content

HDAC7 controls anti-viral and anti-tumor immunity by CD8+ T cells

Advances in Hodgkin Lymphoma Treatment: Clinical Considerations for Managing Toxicities in Nivolumab-AVD Therapy

One of the most promising developments in advanced-stage Hodgkin lymphoma is the nivolumab-AVD regimen, which combines nivolumab with doxorubicin, vinblastine, and dacarbazine. This article provides practical knowledge for advanced practitioners to effectively manage the most common toxicities associated with nivolumab-AVD.

Advancing CAR-T therapy in multiple myeloma: a critical appraisal of CARTITUDE-4 and the path toward earlier lines